Tova Ceccato

Tova Ceccato is currently the Senior Scientific Lead in Cell Biology at Eli Lilly, where they focus on developing new cancer treatments. Tova's scientific career includes serving as a postdoctoral researcher at the University of Colorado Anschutz, where they studied metabolism's impact on pediatric cardiac mechanics. They earned a Ph.D. in molecular biology from the University of Colorado Boulder, working on hydrogels to investigate cardiac fibroblast behavior. Earlier experiences include an internship at Lawrence Livermore National Laboratory, where Tova tested FDA-approved drugs against select agent bacteria.